Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay

Virus Research

Volumn 211, Issue , 2016, Pages 17-24

  Zhang, Pan Tao ^a,b   Shan, Chao ^a   Li, Xiao Dan ^a,b   Liu, Si Qing ^a   Deng, Cheng Lin ^a   Ye, Han Qing ^a   Shang, Bao Di ^a,b   Shi, Pei Yong ^c   Lv, Ming ^d   Shen, Bei Fen ^d   Qin, Cheng Feng ^e   Zhang, Bo ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Antiviral drug discovery; Gaussia luciferase; Neutralizing antibody; Reporter virus; West nile virus

Indexed keywords

GAUSSIA LUCIFERASE; LUCIFERASE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; GENETIC TRANSFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SERODIAGNOSIS; VIRUS CAPSID; VIRUS GENOME; VIRUS PLAQUE; WEST NILE VIRUS; ANIMAL; COPEPOD; DEVICES; EVALUATION STUDY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROCEDURES; VIROLOGY; WEST NILE FEVER;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; COPEPODA; GENES, REPORTER; HUMANS; LUCIFERASES; NEUTRALIZATION TESTS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84951853822     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.09.015     Document Type: Article

References (31)

1. Brinton M.A. Replication cycle and molecular biology of the West Nile virus. Viruses 2014, 6(1):13-53.
2. Calisher C.H., Karabatsos N., Dalrymple J.M., Shope R.E., Porterfield J.S., Westaway E.G., Brandt W.E. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J. Gen. Virol. 1989, 70(Pt 1):37-43.
3. Chung W.M., Buseman C.M., Joyner S.N., Hughes S.M., Fomby T.B., Luby J.P., Haley R.W. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013, 310(3):297-307.
4. Deardorff E., Estrada-Franco J., Brault A.C., Navarro-Lopez R., Campomanes-Cortes A., Paz-Ramirez P., Solis-Hernandez M., Ramey W.N., Davis C.T., Beasley D.W., Tesh R.B., Barrett A.D., Weaver S.C. Introductions of West Nile virus strains to Mexico. Emerg. Infect. Dis. 2006, 12(2):314-318.
5. Deas T.S., Binduga-Gajewska I., Tilgner M., Ren P., Stein D.A., Moulton H.M., Iversen P.L., Kauffman E.B., Kramer L.D., Shi P.Y. Inhibition of Flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 2005, 79(8):4599-4609.
6. Di Gennaro A., Lorusso A., Casaccia C., Conte A., Monaco F., Savini G. Serum neutralization assay can efficiently replace plaque reduction neutralization test for detection and quantitation of West Nile virus antibodies in human and animal serum samples. Clin. Vaccine Immunol. 2014, 21(10):1460-1462.
7. Gyure K.A. West Nile virus infections. J. Neuropathol. Exp. Neurol. 2009, 68(10):1053-1060.
8. Hogrefe W.R., Moore R., Lape-Nixon M., Wagner M., Prince H.E. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other Flavivirus-specific antibodies. J. Clin. Microbiol. 2004, 42(10):4641-4648.
9. Johnson B.W., Kosoy O., Hunsperger E., Beltran M., Delorey M., Guirakhoo F., Monath T. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests. Clin. Vaccine Immunol. 2009, 16(7):1052-1059.
10. Kramer L.D., Styer L.M., Ebel G.D. A global perspective on the epidemiology of West Nile virus. Annu. Rev. Entomol. 2008, 53:61-81.
11. Kuno G. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv. Virus Res. 2003, 61:3-65.
12. Li X.L., Fu S.H., Liu W.B., Wang H.Y., Lu Z., Tong S.X., Li Z.X., Nasci R.S., Kosoy O., Cui Y., Liang G.D. West Nile virus infection in Xinjiang, China. Vector Borne Zoonotic Dis. 2013, 13(2):131-133.
13. Lindsey N.P., Staples J.E., Lehman J.A., Fischer M. Surveillance for human West Nile virus disease-United States, 1999-2008. MMWR. Surveill. Summ. 2010, 59(2):1-17.
14. Lu Z., Fu S.H., Cao L., Tang C.J., Zhang S., Li Z.X., Tusong M., Yao X.H., Zhang H.L., Wang P.Y., Wumaier M., Yuan X.Y., Li M.H., Zhu C.Z., Fu L.P., Liang G.D. Human infection with West Nile virus, Xinjiang, China, 2011. Emerg. Infect. Dis. 2014, 20(8):1421-1423.
15. Luft C., Freeman J., Elliott D., Al-Tamimi N., Kriston-Vizi J., Heintze J., Lindenschmidt I., Seed B., Ketteler R. Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs. BMC Biochem. 2014, 15:14.
16. Mann B.R., McMullen A.R., Swetnam D.M., Barrett A.D. Molecular epidemiology and evolution of West Nile virus in North America. Int. J. Environ. Res. Public Health 2013, 10(10):5111-5129.
17. McGee C.E., Shustov A.V., Tsetsarkin K., Frolov I.V., Mason P.W., Vanlandingham D.L., Higgs S. Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis. 2010, 10(3):267-274.
18. Niedrig M., Sonnenberg K., Steinhagen K., Paweska J.T. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. J. Virol. Methods 2007, 139(1):103-105.
19. Petersen L.R., Marfin A.A. West Nile virus: a primer for the clinician. Ann. Intern. Med. 2002, 137(3):173-179.
20. Pierson T.C., Diamond M.S., Ahmed A.A., Valentine L.E., Davis C.W., Samuel M.A., Hanna S.L., Puffer B.A., Doms R.W. An infectious West Nile virus that expresses a GFP reporter gene. Virology 2005, 334(1):28-40.
21. Puig-Basagoiti F., Qing M., Dong H., Zhang B., Zou G., Yuan Z., Shi P.Y. Identification and characterization of inhibitors of West Nile virus. Antiviral Res. 2009, 83(1):71-79.
22. Rodriguez Mde L., Rodriguez D.R., Blitvich B.J., Lopez M.A., Fernandez-Salas I., Jimenez J.R., Farfan-Ale J.A., Tamez R.C., Longoria C.M., Aguilar M.I., Rivas-Estilla A.M. Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico. Vector Borne Zoonotic Dis. 2010, 10(2):151-157.
23. Shan C., Li X., Deng C., Shang B., Xu L., Ye H., Yuan Z., Zhang B. Development and characterization of West Nile virus replicon expressing secreted Gaussia luciferase. Virol. Sin. 2013, 28(3):161-166.
24. Shang B., Deng C., Ye H., Xu W., Yuan Z., Shi P.Y., Zhang B. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antiviral Res. 2013, 97(2):198-205.
25. Shi P.Y., Tilgner M., Lo M.K., Kent K.A., Bernard K.A. Infectious cDNA clone of the epidemic West Nile virus from New York City. J. Virol. 2002, 76(12):5847-5856.
26. Song K.Y., Zhao H., Jiang Z.Y., Li X.F., Deng Y.Q., Jiang T., Zhu S.Y., Shi P.Y., Zhang B., Zhang F.C., Qin E.D., Qin C.F. A novel reporter system for neutralizing and enhancing antibody assay against dengue virus. BMC Microbiol. 2014, 14:44.
27. Tannous B.A., Kim D.E., Fernandez J.L., Weissleder R., Breakefield X.O. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 2005, 11(3):435-443.
28. Vandergaast R., Hoover L.I., Zheng K., Fredericksen B.L. Generation of West Nile virus infectious clones containing amino acid insertions between capsid and capsid anchor. Viruses 2014, 6(4):1637-1653.
29. Villordo S.M., Gamarnik A.V. Genome cyclization as strategy for Flavivirus RNA replication. Virus Res. 2009, 139(2):230-239.
30. Zhang B., Dong H., Ye H., Tilgner M., Shi P.Y. Genetic analysis of West Nile virus containing a complete 3'CSI RNA deletion. Virology 2010, 408(2):138-145.
31. Zou G., Xu H.Y., Qing M., Wang Q.Y., Shi P.Y. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res. 2011, 91(1):11-19.